Grant of European Patent on Transfection Enhancer Elements

The EPO, Europe’s Patent Agency, today announced the grant of patent EP 2125029 to Lipocalyx GmbH. The invention of “Construction and Use of Transfection Enhancer Elements” introduces the principle of a hydrophobic shift to the field of delivery solutions for nucleic acids.

Dr. Steffen Panzner, CEO of Lipocalyx, comments: “The grant of EP 2125029 is fundamental to our Viromer® technology. The principle of a hydrophobic shift was inspired by the way viruses get into cells. We will further exploit this invention to build delivery systems that eventually compete or outperform viral vectors.”

By | 2017-05-30T18:39:42+00:00 October 12th, 2016|Allgemein|Comments Off on Grant of European Patent on Transfection Enhancer Elements